Previous studies showed that SPON2 expression was significantly associated with prognosis in hepatocellular carcinoma, colorectal cancer, gastric cancer, and lung adenocarcinoma [8–12]. The gene discussed is SPON2; the disease is hepatocellular carcinoma.